Pharmacodynamic interplay of the P2Y1, P2Y12, and TxA2 pathways in platelets: the potential of triple antiplatelet therapy with P2Y1 receptor antagonism

Introduction Previous work suggests that the extent of platelet inhibition by P2Y1 receptor antagonism may be underappreciated, particularly in the context of dual antiplatelet therapy with aspirin and clopidogrel.